NEUROONE MEDICAL TECHNOLOGIES CORPORATION

Communiqués NeuroOne Medical Technologies Corporation

Actions

NMTC

US64130M2098

Marché Fermé - Nasdaq Autres places de cotation 19:30:00 03/07/2024			Varia. 5j.	Varia. 1 janv.
0,85 ^USD	-2,21 %		+14,40 %	-46,20 %

25/06	NeuroOne® annonce les premières ablations chez l'homme réalisées avec le système d'ablation OneRF ? Ablation System	CI
20/06	NeuroOne annonce que le système d'ablation OneRF reçoit un code de procédure de la part du CMS	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

NeuroOne Announces First in Human Ablations Completed with OneRF Ablation System	26/06	AQ
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System	25/06	AQ
NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation	20/06	AQ
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	14/05	AQ
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14	10/05	AQ
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology	10/04	AQ
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes	09/04	AQ
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.	04/04	AQ
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System	26/03	AQ
NeuroOne to Participate in the 36th Annual Roth Conference	11/03	AQ
NeuroOne® to Participate in the 36th Annual Roth Conference	08/03	AQ
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	23/02	AQ
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	13/02	AQ
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13	08/02	AQ
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update	14/12	AQ
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System	11/12	AQ
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14	07/12	AQ
Thinking about buying stock in Adial Pharmaceuticals, Ares Capital Corp, SilverSun Technologies, Neuroone Medical Technologies, or enGene Holdings?	05/12	PR
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe	16/11	AQ
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	14/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués NeuroOne Medical Technologies Corporation

Actions

NMTC

US64130M2098

Communiqués

Filtres